Detection and control of influenza outbreaks in well-vaccinated nursing home populations

Clinical Infectious Diseases

Volumn 39, Issue 4, 2004, Pages 459-464

  Monto, Arnold S ^a   Rotthoff, Judy ^a   Teich, Esther ^a   Herlocher, M Louise ^a   Truscon, Rachel ^a   Yen, Hui Ling ^a   Elias, Stephanie ^a   Ohmit, Suzanne E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; VIRUS ANTIGEN;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EPIDEMIC; FALLING; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MUSCLE SPASM; NAUSEA; NEUROLOGIC DISEASE; NURSING HOME; PRIORITY JOURNAL; SEIZURE; SKIN IRRITATION; TREMOR; UNITED STATES; VACCINATION; VIRUS CULTURE; VIRUS DETECTION; VIRUS ISOLATION; VIRUS TRANSMISSION; VOMITING;

ACETAMIDES; AGED; ANTIVIRAL AGENTS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DISEASE OUTBREAKS; HOMES FOR THE AGED; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MICHIGAN; NURSING HOMES; OBSERVATION; OSELTAMIVIR; POPULATION SURVEILLANCE; SEASONS; SENSITIVITY AND SPECIFICITY;

EID: 4344637608     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/422646     Document Type: Article

References (26)

1. Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985; 253:1136-9.
2. Ohmit SE, Arden NH, Monto AS. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. J Am Geriatr Soc 1999; 47:165-71.
3. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2002; 51:1-31.
4. Anderson RM, May RM. Immunization and herd immunity. Lancet 1990; 335:641-5.
5. Strassburg MA, Greenland S, Sorvillo FJ, Lieb LE, Habel LA. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4:38-44.
6. Phair J, Kauffman CA, Bjornson A, et al. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med 1978; 92:822-8.
7. Monto AS. The role of antivirals in the control of influenza. Vaccine 2003; 21:1796-800.
8. Nicholson KG. Use of antivirals in influenza in the elderly: prophylaxis and therapy. Gerontology 1996; 42:280-9.
9. Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomized controlled trials. BMJ 2003; 326:1235.
10. Monto AS, Arden NH. Implications of viral resistance to amantadine in control of influenza A. Clin Infect Dis 1992; 15:362-7.
11. Degelau J, Somani S, Cooper SL, et al. Occurrence of adverse effects and high amantadine concentrations with influenza prophylaxis in the nursing home. J Am Geriatr Soc 1990; 38:428-32.
12. Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet 2000; 355:827-35.
13. McClellan K, Perry CM. Oseltamivir: a review of its use in influenza. Drugs 2001; 61:263-83.
14. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000; 160:3243-7.
15. Monto AS, Ohmit SE, Margulies JR, et al. Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. Am J Epidemiol 1995; 141;:502-6.
16. Herrmann B, Larsson C, Zweygberg BW. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 2001; 39:134-8.
17. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine. MMWR Morb Mortal Wkly Rep 2001; 50:466-70.
18. Centers for Disease Control and Prevention. Update: influenza activity - United States and worldwide, 2001-02 season, and composition of the 2002-03 influenza vaccine. MMWR Morb Mortal Wkly Rep 2002; 51:503-6.
19. Arden NH, Monto AS, Ohmit SE. Vaccine use and risk of outbreaks in a sample of nursing homes during an influenza epidemic. Am J Pub Health 1995; 85:399-401.
20. Li J, Birkhead GS, Strogatz DS, et al. Impact of institutional size, staffing patterns, and infection control practices on communicable disease outbreaks in New York state nursing homes. Am J Epidemiol 1996; 143: 1042-9.
21. Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999; 281:908-13.
22. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175:1-6.
23. Falsey AR. Noninfluenza respiratory virus infection in long-term care facilities. Infect Control Hosp Epidemiol 1991; 12:602-8.
24. Ruest A, Michaud S, Deslandes S, et al. Comparison of the Directigen Flu A + B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 2003; 41:3487-93.
25. Bowles SK, Lee W, Simor AE, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 2002; 50:608-16.
26. Strausbaugh LJ, Sukumar SR, Joseph CL. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis 2003; 36:870-6.